Dr. Gerald I. Shulman of Yale School of Medicine Wins 2025 ALF Award
Dr. Gerald I. Shulman's Prestigious Recognition
The American Liver Foundation (ALF) has announced that Dr. Gerald I. Shulman, a prominent figure at Yale School of Medicine, is set to receive the Distinguished Scientific Achievement Award (DSAA) in 2025. This recognition reflects Dr. Shulman’s profound impact on liver research, particularly his focus on the connections between liver disease and diabetes.
Dr. Shulman serves as the George R. Cowgill Professor of Medicine and Cellular and Molecular Physiology at Yale. He is also the Co-Director of the Yale Diabetes Research Center. His award will be presented at a special reception on November 10, 2025, during the American Association for the Study of Liver Diseases' annual meeting.
Innovations in Liver Disease Research
The decision to grant Dr. Shulman this award is based on his pioneering contributions to understanding how insulin resistance affects liver function. Lorraine Stiehl, the CEO of ALF, highlighted Dr. Shulman’s commitment to scientific excellence, stating, “His groundbreaking work has transformed our understanding of insulin resistance and its role in liver diseases, thus paving the way for new therapeutic options.” This year marks a historic moment, as Dr. Shulman becomes the first endocrinologist and physician-scientist to receive this honor from ALF.
Dr. Shulman has dedicated over 38 years to innovative diabetes and liver disease research. His team's notable discovery of
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.